PULM Pulmatrix Inc Yalpi foyda bo'yicha rentabellik

PULM (Pulmatrix Inc) - kompaniyaning tovar belgisi

Baza yalpi foyda ko'rsatkichi Pulmatrix, Inc. (PULM) moliyaviy samaradorligini namoyish etadi, bunda 0.00 belgisi eng so'nggi ma'lumotlarni aks ettiradi. Ushbu tendentsiya FDA tasdig'iga va kapital xarajatlar sur'atiga bog'liq. O'pka davolash uchun iSPERSE tizimining ishlab chiqilishi biotexnologik hubning asosini yaratadi. Barqaror laboratoriya operatsiyalari va sinov jadvaliga rioya qilish ishlab chiqarishdagi turg'unlik vaqtlarini bartaraf etadi.

Pulmatrix Corporation (PULM) Yalpi foyda bo'yicha rentabellik: 04.07.2022 - 19.11.2026 davri uchun

pulmatrix.com (PULM) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahlili:Pulmatrix Corp
Pulmatrix, Inc. tomonidan chiqariladigan mahsulotlar

Yalpi foyda marjasi biznes modelining hayotiyligini baholash uchun bevosita ishlab chiqarish xarajatlaridan keyin qolgan daromad qismini aniqlash orqali operatsion samaradorlikni o'lchaydi. Yalpi foyda marjasini tahlil qilish orqali investor Pulmatrix, Inc. (PULM) kompaniyasining testlarni autsorsing qilish va ixtisoslashgan olimlar shtatini optimallashtirish strategiyasining ta'sirini ko'rishi mumkin, bu esa kompaniyaga inhalatsiya tizimlarini ishlab chiqish uchun ichki xarajatlarni minimallashtirish imkonini beradi.

Muhim raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|AMPH: Yalpi foyda normasi|Yalpi rentabellik pacira.com (PCRX)|Yalpi marja ARS Pharma (SPRY)|Theravance Biopharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Tectonic Therapeutic|TNXP: Yalpi marja|SXT China (SXTC) - Yalpi marja|Yalpi rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Invizyne (EXOZ)|ORMP - Yalpi foyda marjasi|Yalpi marja ENTX (Entera Bio)|Sotuvning yalpi marjinal rentabelligi MindWalk Therapeutics|ABVC: Yalpi foyda bo'yicha rentabellik|CPIX - Yalpi marja|QNTM (Quantum BioPharma) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha marjinallik FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Yalpi marja|Yalpi marja ranitherapeutics.com|Yalpi rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Sotuvning yalpi rentabelligi|lexariabioscience.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda koeffitsiyenti PTHL (Pheton)|APM - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Yalpi rentabellik|TNF Pharma (TNFA) - Yalpi marja|YCBD (cbdmd.com) - Yalpi marja|Yalpi foyda bo'yicha rentabellik PainReform (PRFX)|Yalpi rentabellik Altamira Therapeutics (CYTO)|Yalpi foyda bo'yicha sotuv rentabelligi Lipella Pharma|Optinose - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi pieris.com (PIRS)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja